Search results
Results from the WOW.Com Content Network
Mandate The World Health Organization has a constitutional mandate to "develop, establish and promote international standards with respect to biological, pharmaceutical and similar products". The World Health Organization collaborates closely with INN experts and national nomenclature committees to select a single name of worldwide ...
The National Institute for Biological Standards and Control (NIBSC) is a government agency that works in the field of biological standardisation and is part of the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA). It is responsible for developing and producing over 90% of the biological international standards in use ...
Ministries of health in several sub-Saharan African countries, including Zambia, Uganda, and South African, were reported to have begun planning health system reform including hospital accreditation before 2002. However, most hospitals in Africa are administered by local health ministries or missionary organizations without accreditation programs.
The International Health Terminology Standards Development Organisation (IHTSDO), trading as SNOMED International, is private company limited by guarantee and established under the laws of England [1] that owns SNOMED CT, a leading clinical terminology used in electronic health records.
NSF (an initialism for National Sanitation Foundation) is a public health organization [1] headquartered in Ann Arbor, Michigan [2] that tests and certifies foods, water, and consumer products. [1] It also facilitates the development of standards for these products, [1] labeling products it has certified to meet these standards with the NSF ...
Health Level Seven International (HL7) is a non-profit ANSI-accredited standards development organization that develops standards that provide for global health data interoperability. The 2.x versions of the standards are the most commonly used in the world.
In the 1980s, the European Union began harmonising regulatory requirements. In 1989, Europe, Japan, and the United States began creating plans for harmonisation. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) was created in April 1990 at a meeting in Brussels.
A similar guideline for clinical trials of medical devices is the international standard ISO 14155, which is valid in the European Union as a harmonized standard. These standards for clinical trials are sometimes referred to as ICH-GCP or ISO-GCP to differentiate between the two and the lowest grade of recommendation in clinical guidelines.